-
China's first mRNA vaccine was approved in Indonesia, and nearshore protein will explain the vaccine for you
Time of Update: 2022-10-25
In addition to raw material supply, nearshore protein is also developing mRNA stock solution preparation and detection processes to provide customers with more comprehensive services.
In addition to raw material supply, nearshore protein is also developing mRNA stock solution preparation and detection processes to provide customers with more comprehensive services.
-
The rapid growth of new channel consumption will detonate the market for ginseng products!
Time of Update: 2022-10-25
Please pay attention to the selected video "Development Status and Trend Analysis of Ginseng Products in 2022" recently launched by the TCM Industry Big Data Platform of TNT-Cloud Map. The release of the "Healthy China 2030" Plan Outline in 2016 marked the elevation of "Healthy China" to a national strategy.
-
Products continue to be approved, and there are long-term development opportunities in China's API industry
Time of Update: 2022-10-25
Northeast Pharmaceutical recently reported that the company's acetyl-levocarnitine hydrochloride API has been approved by the Drug Review Center of the State Medical Products Administration, and has received the "Chemical API Marketing Application Approval Notice" approved and issued by the State Medical Products Administration.
-
Digital intelligence empowers Zhangshu, the "pharmaceutical capital of China" The annual revenue of the pharmaceutical industry exceeds 100 billion yuan
Time of Update: 2022-10-25
"We strive to build Geshushan Mountain Area into a national 5A-level tourist attraction in five years, develop a number of tourism commodities, traditional Chinese medicine meals and health foods with the characteristics of the medicine capital, and enhance the tourism image of 'China's medicine capital and health blessing land'.
-
Beijing: Strive to achieve direct inter-provincial settlement of general outpatient clinics within this year
Time of Update: 2022-10-25
5 billion yuan in drug costs。 The reporter recently learned from the Beijing Municipal Medical Security Bureau that by the end of this year, all designated medical institutions with the ability to receive treatment in the city will have full coverage of direct settlement of ordinary outpatient expenses across provinces.
-
The State Food and Drug Administration issued the 6th batch of reference preparations for generic drugs
Time of Update: 2022-10-25
0mg Janssen-Cilag/Karo Pharma No original drugs have been imported Added licensee Karo Pharma 42-36 Paroxetine hydrochloride tablets Paroxetine Hydrochloride Tablets 20mg (in terms of C19H20FNO3) Sino-American Tianjin SmithKline Pharmaceutical Co.
-
Macao hosted the 2022 Global Summit on the Digitalization of Traditional Chinese Medicine
Time of Update: 2022-10-25
(End) On October 21, the "9th Annual Conference of the Chinese Medicine Appraisal Professional Committee of the World Federation of Chinese Medicine Societies" and the "2022 Global Summit Forum on the Digitalization of Chinese Medicine" were officially opened in Macao.
-
East Sunshine's first generic patent challenged the original research successfully, and fingolimod capsules were approved for marketing in the United States
Time of Update: 2022-10-25
On October 18, 2022, the US court officially ruled that the US9187405 patent was invalid, and fingolimod capsules were officially put on sale in the United States, marking East Sunshine becoming the first Chinese company to challenge the original drug patent in the United States and succeed.
-
Local API companies continue to have good news, which is related to the approval of products and the passage of inspection
Time of Update: 2022-10-25
js?cdnversion='+~(-new Date()/36e5)]; Recently, Tonghe Pharmaceutical issued an announcement that the APIs mirabelon and rivaroxaban passed the drug GMP (Good Manufacturing Practice) compliance inspection.
js?cdnversion='+~(-new Date()/36e5)]; Recently, Tonghe Pharmaceutical issued an announcement that the APIs mirabelon and rivaroxaban passed the drug GMP (Good Manufacturing Practice) compliance inspection.
-
More than 20 billion yuan of anti-anemia drug market, domestic pharmaceutical companies are actively layout
Time of Update: 2022-10-25
45 billion yuan in 2021, and it is expected that the scale of China's anti-anemia drug market will reach 26.
45 billion yuan in 2021, and it is expected that the scale of China's anti-anemia drug market will reach 26.
-
81 new Chinese medicine pieces will be included in the province's medical insurance payment coverage!
Time of Update: 2022-10-25
js?cdnversion='+~(-new Date()/36e5)]; In recent years, traditional Chinese medicine has received different degrees of policy support in terms of strategic position, standardized development mode, price, payment end, medical insurance immunization, sales end and innovation rhythm.
-
NMPA: Revised the instructions for 4 varieties such as pentoxifylline injection
Time of Update: 2022-10-25
） Source: NMPA Editor: wangxinglai2004 On October 18, 2022, the State Food and Drug Administration issued an announcement that, based on the results of adverse drug reaction assessment, in order to further protect the safety of public drug use, the State Medical Products Administration decided to uniformly revise the content of the instructions of pentoxifylline injection (including pentoxifylline injection, pentoxifylline for injection, pentoxifylline sodium chloride injection, pentoxifylline glucose injection).
-
Under the "involution" of the generic drug market, domestic pharmaceutical companies are accelerating their "going abroad"
Time of Update: 2022-10-25
On October 19, Huahai Pharmaceutical announced that the new drug abbreviated application for dimethyl fumarate sustained-release capsules (ANDA, that is, the US generic drug application) declared to the US Food and Drug Administration (FDA) has been approved.
-
Traditional Chinese medicinal materials in Yili Prefecture, Xinjiang have ushered in a one-year harvest period
Time of Update: 2022-10-21
On October 9, Yang Haihua, a villager in Wuzunbulak Town, Zhaosu County, Yili Prefecture, was busy digging for Chinese medicinal materials in the field: "Our family planted 400 acres of solitary work this year, and the overall growth is still relatively good, and the net income of about 400,000 yuan can be removed from the cost, and the benefits are still considerable.
-
State Food and Drug Administration: Guidelines for the verification of medical device registration quality management system
Time of Update: 2022-10-21
1 (Quality Management System) The registration applicant (hereinafter referred to as the applicant) shall, in accordance with the requirements of the Good Manufacturing Practice for Medical Devices and its appendices, establish a quality management system suitable for the product realization process based on scientific knowledge, experience and risk management principles, including commissioned production (if any), clinical evaluation (including clinical trials), etc.
-
Traditional Chinese medicine sector: It is recommended to pay attention to Chinese medicine formula granules and brand OTC enterprises
Time of Update: 2022-10-20
Red Sun Pharmaceutical is expected to grow rapidly in volume and price in 2023 Hongri Pharmaceutical is a traditional Chinese medicine enterprise controlled by Tianjin State-owned Assets Supervision and Administration Commission, which currently has a layout of traditional Chinese medicine formula granules, finished drugs, medical devices, raw and auxiliary materials, medical and health services and intelligent supply chain of pharmaceutical devices.
-
Strictly control the cost of raw materials, Tasly's main business growth!
Time of Update: 2022-10-20
According to the 2022 half-year report of Tasly Pharmaceutical Group Co. , Ltd. (Tasly, 600535), the company achieved operating income of 4. 011 billion yuan in the first half of the year, a year-on-
-
In the 5G era, the development of pharmaceutical companies presses the "fast forward button"!
Time of Update: 2022-10-20
【Pharmaceutical Network Industry News】In the ointment production workshop of Ma Yinglong, a traditional Chinese medicine enterprise, through the application of 5G technology, almost all production pro
-
The development of First in class drugs also needs to meet unmet clinical needs
Time of Update: 2022-10-20
However, recently, the first in class diabetes drug "Dopagliatin Tablets" has fallen in stock price after being approved for marketing, which has aroused the attention of the industry.
-
Within half a month, a number of pharmaceutical companies approved their API products
Time of Update: 2022-10-20
On October 11, Lifang Pharmaceutical announced that the company recently received the "Acceptance Notice" for the marketing registration application of nifedipine API issued by the State Medical Products Administration.
